Related Experiment Video

Updated: Jun 1, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Activation of liver X receptor decreases BACE1 expression and activity by reducing membrane cholesterol levels

Weigang Cui1, Yan Sun, Zhongping Wang

  • 1Department of Anatomy, Histology and Embryology, Shanghai Medical College, Fudan University, 200032 Shanghai, China.

Neurochemical Research
|June 2, 2011
PubMed

Insights

Liver X receptor (LXR) activation by T0901317 reduces beta-secretase 1 (BACE1) activity and cholesterol levels in Alzheimer's disease models. This neuroprotective effect is mediated by ATP-binding membrane cassette transport protein A1 (ABCA1).

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • The synthetic Liver X receptor (LXR) activator T0901317 shows potential neuroprotection in Alzheimer's disease.
  • The precise link between LXR activation and beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) remains unclear.

Purpose of the Study:

  • To investigate the impact of T0901317 on membrane cholesterol, BACE1 expression, and activity.
  • To elucidate the role of ATP-binding membrane cassette transport protein A1 (ABCA1) in mediating LXR's effects.

Main Methods:

  • In vivo and in vitro experiments using T0901317.
  • Assays for membrane cholesterol levels, BACE1 expression and activity, and beta-CTF levels.
  • Experiments involving ABCA1 inhibition and LXR antagonism.

Main Results:

  • T0901317 decreased membrane cholesterol, BACE1 expression/activity, and beta-CTF levels.
  • T0901317 enhanced ATP-binding membrane cassette transport protein A1 (ABCA1) expression.
  • ABCA1 inhibition and LXR antagonism reversed T0901317's effects on cholesterol and BACE1 activity.

Conclusions:

  • LXR activation by T0901317 reduces BACE1 expression and activity.
  • This reduction is associated with ABCA1-mediated decrease in membrane cholesterol levels.
  • LXR activation represents a potential therapeutic strategy for Alzheimer's disease by targeting BACE1 via cholesterol regulation.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...